The incidence of inflammatory bowel disease (IBD) has been increasing in recent years; nevertheless, neonatal IBD with gene mutations are rare with great therapeutic challenges. Herein, we reported a case of very early onset inflammatory bowel disease (VEO-IBD) with an gene mutation which was effectively treated by adalimumab.
展开▼